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Maintenance of adequate renal function after living kidney donation is important for donor 26 
outcome. Overweight donors in particular may have an increased risk for end stage kidney 27 
disease (ESKD), and young female donors have an increased preeclampsia risk. Both of these 28 
risks may associate with low post-donation renal functional reserve (RFR). Because we 29 
previously found that higher BMI and lower post-donation RFR were associated, we now 30 
studied the relationship between BMI and RFR in young female donors. RFR, the rise in 31 
GFR (
125
I-Iothalamate clearance) during dopamine, was measured in female donors (<45 32 
years) before and after kidney donation. Donors who are overweight (BMI>25) and non-33 
overweight donors were compared by t-test; the association was subsequently explored with 34 
regression analysis. We included 105 female donors (age 41 [36-44] (median[IQR])) with a 35 
BMI of 25 [22-27] kg/m
2
. Pre-donation GFR was 118 (17) ml/min (mean(SD)) rising to 128 36 
(19) ml/min during dopamine; mean RFR was 10 (10) ml/min. Post-donation GFR was 76 37 
(13) ml/min, rising to 80 (12); RFR was 4 (6) ml/min (p<0.001 vs. pre-donation). In 38 
overweight donors, RFR was fully lost after donation (1 ml/min vs. 10 ml/min pre-donation, 39 
p<0.001), and BMI was inversely associated with RFR after donation, independent of 40 
confounders (St. β 0.37, p=0.02). Reduced RFR might associate with the risk of preeclampsia 41 
and ESKD in kidney donors. Prospective studies should explore whether RFR is related to 42 
preeclampsia and whether BMI reduction prior to conception is of benefit to overweight 43 
female kidney donors during and after pregnancy. 44 
  45 
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Living donor kidney transplantation is the preferred treatment for patients with end-stage 47 
kidney disease (ESKD), providing better outcomes compared to either dialysis or 48 
transplantation of a kidney from a deceased donor(25). Although efficient living donor 49 
programs have been established, a shortage of donor organs still exists, which has led to 50 
liberalization of selection criteria for the living donor(29). Nowadays, donors with a high 51 
body mass index (BMI) are more often eligible for donation, leading to an increased number 52 
of obese donors(24). However, donors may have an increased risk for ESKD, in particular 53 
when they are obese(23). 54 
After kidney donation, vasodilation occurs in the remaining kidney as a compensatory 55 
response to maintain glomerular filtration rate (GFR) (21); as a logical consequence, the 56 
vasodilatory reserve capacity decreases(31, 39, 41). In 2008, Rook et al. showed that in living 57 
kidney donors, a higher donor BMI was associated with loss of renal functional reserve 58 
(RFR). This was assessed as the dopamine response, also known as reserve capacity(32). 59 
RFR was fully lost in older donors with BMI > 30 kg/m
2
, while they maintained an adequate 60 
GFR in the short term. However, the implication of loss of RFR for long-term outcomes in 61 
obese donors has not yet been established. 62 
Obesity is also a major risk factor for preeclampsia (PE). Of note, Garg et al. reported a 63 
significantly increased risk to develop gestational hypertension or preeclampsia (PE) (15), 64 
extending earlier survey data (18, 30). During normal pregnancy renal blood flow and GFR 65 
increase during the first half of pregnancy (8, 19, 22). Absence of pregnancy-induced renal 66 
vasodilation and absence of the hyperfiltration of pregnancy are hallmarks of PE (8, 12,28). 67 
A low RFR in young female donors, as a possible indicator of reduced renal vasodilator 68 
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capacity, may therefore be relevant to the findings by Garg et al. and others on PE risk (15, 69 
18, 30). 70 
Due to the low number of young female kidney donors included in the 2008 study, Rook et 71 
al. mainly found an effect in older donors and were unable to draw conclusions on either loss 72 
or preservation of RFR in women of childbearing age (32). We hypothesized that renal RFR 73 
is lost in overweight young female donors after donation. In the current study, therefore, we 74 
studied the relationship between BMI and renal RFR by dopamine response before and after 75 
donation in female donors of childbearing age. 76 
  77 
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Materials and Methods 78 
We performed a retrospective cohort study, consisting of 105 living female kidney donors 79 
between 18 and 45 years old, who donated between 1992 and 2016 at the University Medical 80 
Center Groningen. Data was collected from the living donors screening and follow-up 81 
program in our center, at four months before and two months after donation. The study was 82 
approved by the institutional review board (METc 2014/077) and was conducted in 83 
accordance with the declaration of Helsinki. 84 
Renal function measurements 85 




I-hippurate infusion as described 86 
(32): Measurements were performed in a quiet room, with the subject in semi-supine 87 




I-hippurate infusions were 88 
given (0.04 mL/kg containing 0.04 MBq and 0.03 MBq respectively). At 08.00 hour 0.6 MBq 89 
of 
125
I-Iothalamate was administered, followed by continuous infusion of 12 mL/h. After a 90 
two-hour stabilization period, baseline measurements started in a steady state of plasma tracer 91 
levels. Clearances were calculated as (U*V)/P and (I*V)/P, where U*V represents the urinary 92 
excretion, I*V represents the infusion rate of the tracer and P represents the plasma tracer 93 
concentration per clearance period. From clearance levels of these tracers, GFR, effective 94 
renal plasma flow (ERPF) and filtration fraction (FF) were calculated. Correction for 95 
incomplete bladder emptying and dead space was achieved by multiplying the urinary 
125
I-96 
Iothalamate clearances with plasma and urinary 
131
I-hippurate clearance. Day-to-day 97 
variability of GFR is 2.5% (1). 98 
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Renal functional reserve (RFR), expressed as the change in GFR in ml/min, was measured by 99 
extending the above-mentioned procedure by two hours with a dopamine infusion of 1.5 100 
µg/kg/min (38). 101 
Clinical and biochemical measurements 102 
At both time points, height, weight and blood pressure measurements were collected. 103 
Conforming to selection criteria of our kidney donor program, all donors were normotensive 104 
or had adequately regulated blood pressure with a maximum of one antihypertensive drug. 105 
Use of anti-hypertensives was very low (3%); adjustment of the analysis for use of anti-106 
hypertensives did not change the conclusions, and is therefore not included in this paper. 107 
Furthermore, subjects with a history of diabetes (or an abnormal glucose tolerance test), 108 
kidney disease or cardiovascular events were excluded from kidney donation. Use of 109 
contraceptives (9%) was underreported and not included in our analysis. BMI was calculated 110 
as (body weight/height
2), where a BMI ≥25 kg/m2 was considered as being overweight. 111 
Proteinuria (g/24h) was measured from 24-hour urine collection by a standard assay. 112 
Statistical analysis  113 
Data are reported as mean (standard deviation, SD) for normally distributed variables and 114 
median [interquartile range, IQR] for skewed data. Binary variables are shown as “number 115 
(%)”. GFR data are reported as absolute values (mL/min) and normalized for body surface 116 
area (BSA; mL/min/1.73m
2
) as well as height (mL/min/m). This was done because BSA and 117 
BMI are strongly correlated. Accordingly, BSA-adjustment, although customary in the 118 
literature, induces a systematic error in analyses for possible associations with BMI(10). In 119 
line with prior papers(4) we therefore report height-normalized values along with BSA-120 
normalized values. RFR is reported as change in GFR in mL/min during dopamine infusion.  121 
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A t-test was used to determine differences between normal and overweight kidney donors, 122 
after transformation of skewed data. If data remained skewed after transformation, a Mann-123 
Whitney U test was performed. To investigate association between BMI and RFR after 124 
donation, linear regression analysis was performed with BMI as independent and difference 125 
in RFR as dependent variable. We adjusted for potential confounders (GFR, age) in 126 
subsequent multivariable analysis. Statistical analyses were performed by SPSS version 22 127 
for Windows (IBM, Armonk, NY) and Graphpad Prism 6 for Windows (Graphpad, San 128 
Diego, CA). P-values of <0.05 were considered statistically significant. 129 
  130 
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Pre- and post-donation characteristics 132 
We included 105 female living kidney donors who were 41 [36-44] years old at donation, 133 
with a BMI of 25 [22-27] kg/m
2
. Before donation, the GFR was 118 (17) mL/min, rising to 134 
128 (19) mL/min during dopamine. The ERPF was 405 (74) mL/min, rising to 496 (113) 135 
mL/min during dopamine. Pre-donation characteristics are shown in table 1 by a break-up of 136 
BMI at 25 kg/m
2
. A higher BMI was associated with elevated GFR, both when expressed 137 
nominally and after normalization to height, indicating overweight-associated 138 
“hyperfiltration” (figure 1A and 1B). The RFR was 10 (10) mL/min, with no difference 139 
between the BMI categories.  140 
At 2 months after donation (57 [50-63] days; table 2), mean GFR was 76 (13) mL/min rising 141 
to 80 (12) during dopamine. The break-up by BMI shows that nominal and height-adjusted 142 
GFR were significantly higher in overweight donors (figure 1C and 1D). ERPF was 286 (49) 143 
mL/min, rising to 332 (65) mL/min during dopamine. Post-donation RFR was 4 (6) mL/min, 144 
with a remarkable difference between the BMI categories. In the donors with a BMI <25 145 
kg/m
2
 RFR was 6 (5) mL/min, whereas in donors with a BMI ≥ 25 kg/m2 RFR was 146 
completely lost (1 (7) mL/min, p=0.002 vs. BMI <25 kg/m
2
). The absolute change in RFR 147 
from pre- to post-donation was significantly different between BMI groups (low BMI -4 (7) 148 
mL/min, vs. high BMI -8 (6) mL/min, p=0.01).  149 
Association between BMI and renal hemodynamics 150 
BMI was positively associated with GFR, both before (st. β 0.31, p=0.001) and after donation 151 
(st. β 0.36, p<0.001). BMI was inversely associated with post-donation RFR (st. β -0.32, 152 
p=0.003), but not with pre-donation RFR (st. β 0.07, p=0.49). The association between BMI 153 
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and post-donation RFR was independent of donor GFR, age and blood pressure (st. β -0.33, 154 
p=0.004, table 3). When excluding donors with a BMI over 35 (n=2), the results of model 155 
remained materially similar (st. β -0.36, p=0.003). There was no effect modification by age 156 
(pinteraction=0.62). Furthermore, BMI was inversely associated with the absolute change in 157 
RFR before vs. after donation (st. β -0.24, p=0.02). 158 
  159 
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In this study, we observed that BMI is inversely associated with RFR, measured by dopamine 161 
infusion, after kidney donation in women of childbearing age. Moreover, RFR was fully lost 162 
in overweight women after donation, suggesting that in the female kidney donor with a high 163 
BMI, RFR is consumed after kidney donation. 164 
After kidney donation, vasodilatation occurs as a compensatory response to adapt to the 165 
single-kidney state(39). This results in a single-kidney GFR of approximately 66% of the 166 
prior two-kidney state, instead of approximately 50%(36). In this cohort of female donors of 167 
childbearing age we found a similar hemodynamic response (post-donation GFR was 64% of 168 
pre-donation GFR). Based on our results, we hypothesize that hyperfiltration due to the 169 
combination of overweight and donation prevents further increase in GFR in response to 170 
dopamine(3, 35). 171 
Being overweight is associated with distinct renal hemodynamic effects, i.e. a rise in ERPF 172 
and a relatively greater rise in GFR. This results in a rise of filtration fraction (4), in 173 
particular when associated with a central fat distribution(20). These associations are also 174 
present in single kidneys, i.e. after donation (current data) and in transplanted kidneys(5). 175 
Only in the single kidney state is a negative association of BMI with the GFR response to 176 
dopamine observed. Recently it was shown that the higher GFR in overweight patients is 177 
associated with a higher single-nephron GFR. Additionally, this is associated with larger 178 
glomeruli, and with more glomerulosclerosis and arteriolosclerosis than expected for age(11). 179 
The latter supports the assumption that an elevated single nephron GFR contributes to 180 
glomerular injury(17). Unfortunately, data on single nephron GFR and RFR in single kidneys 181 
are lacking so far.  182 
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Prompted by the report on increased PE risk post-donation (15), we focused on women of 183 
childbearing age. Absence of pregnancy-induced renal vasodilation is a hallmark of PE(8, 184 
12,25). Our data raise the hypothesis that loss of renal vasodilator capacity, as reflected by 185 
loss of RFR after donation in overweight women, could be involved in the increased risk for 186 
PE after donation. This hypothesis is also strengthened by the fact that obesity is an important 187 
risk factor for PE (42). Unfortunately, Garg et al do not report BMI and accordingly, it is 188 
unknown from their study, whether the donors with PE were overweight(15). Other possible 189 
factors in the increased risk of PE after donation include the loss of GFR, direct effects of 190 
obesity on placental development(34) or effects of high blood pressure(6). In our study, we 191 
found that the association between BMI and RFR was independent of blood pressure. 192 
Our results are in line with previous studies showing that higher BMI is associated with more 193 
RFR loss post-donation in female and male donors(26, 32). Dopamine, a prominent 194 
vasodilator, was used to induce renal vasodilatation and hence estimate RFR. In line with 195 
prior studies RFR is thus assessed as the acute hemodynamic response to a pharmacological 196 
trigger(40). Dopamine is an endogenous catecholamine that acts on dopaminergic receptors, 197 
which are also present in the kidney(12). It thus elicits dilatation of arterioles, both afferent 198 
but predominantly efferent, resulting in a rise of renal blood flow and GFR(39). Because of 199 
safety concerns and cardiovascular effects of dopamine infusions, a low-dose is used for 200 
testing RFR. The renal hemodynamic response therefore does not reflect the maximum 201 
vasodilator capacity, which likely reduces the sensitivity of RFR to detect subtle changes in 202 
glomerular hemodynamics and microvasculature. Thus, we speculate that absence of an 203 
association between BMI and RFR before donation may be due to lack of sensitivity of RFR. 204 
Alternatively, differential effects of being overweight and dopamine on afferent-efferent 205 
vasomotor balance before and after donor nephrectomy may have been involved. 206 
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What could be the implications of a reduced RFR? The concept of RFR originates from the 207 
1980’s, starting from the notion that nephron loss generally does not lead to a corresponding 208 
loss in GFR, as is readily apparent after kidney donation, indicating that the kidney has some 209 
form of functional reserve(27, 37). The hypothesis was that loss of reserve capacity might 210 
better indicate the extent of nephron loss than GFR and accordingly, that loss of RFR might 211 
be a useful prognostic parameter for future renal function(40). However, this hypothesis has 212 
not been substantiated, due to a general paucity of data on sufficiently powered cohorts where 213 
both RFR and long term follow-up are available. Cross-sectional studies found RFR to be 214 
inversely associated with old age(14) and advancing stages of CKD (2). The short-term 215 
prognostic effects of RFR after donation have been reported by our group (33), showing that 216 
pre-donation RFR has a modest predicting effect for GFR shortly- after donation(33). Work 217 
on long term follow-up is still in progress. 218 
The main limitation of our paper is the lack of long-term renal data and lack of data on 219 
pregnancy outcomes of living kidney donors. Also, the predictive effect of BMI is subtle and 220 
we have insufficient data to adjust for use of contraceptives or menstrual cycle period, which 221 
both influence renal hemodynamics(7). However, the effect of BMI on RFR is consistent in 222 
donors with only mild overweight (we included only two donors with a BMI over 35). Our 223 
study does not have sufficient power to show effects of BMI on ERPF reserve capacity, 224 
which can be relevant since the exact mechanism of “hyperfiltration” after donation is not yet 225 
clarified and may be dependent on glomerular hypertrophy(21).  226 





I-hippurate infusions, instead of per-bolus administration. 228 
Our study links a modifiable risk factor, namely overweight, to RFR in young kidney donors. 229 
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Further studies are needed to study the effect of weight interventions on RFR in overweight 230 
women of childbearing age.  231 
In conclusion, this study shows that overweight women of childbearing age have a 232 
diminished RFR after kidney donation. Long-term studies should substantiate the role of 233 
reduced RFR on long-term renal outcome and PE. Since the incidence of overweight amongst 234 
donors is rising, and BMI is an independent risk factor for ESKD(16, 23), a clear 235 
understanding of the impact of lifestyle on living donation is warranted. Prospective studies 236 
should explore whether BMI reduction prior to conception is of benefit to overweight female 237 
kidney donors during and after pregnancy. 238 
 239 
  240 
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Figure Captions: 377 
Figure 1: GFR before and during dopamine in donors grouped according to BMI. 378 
 (A) Pre-donation GFR. (B) Pre-donation GFR normalized for height. (C) Post-donation GFR 379 
(D) Post-donation GFR normalized for height. Donors with a BMI ≥ 25 kg/m2 post-donation 380 
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Table 1: Pre-donation donor characteristics 401 
Variable 





Age (years) 41 [36-44] 41 [38-44] 41 [36-44] 0.37 
Systolic blood pressure (mmHg) 120 (10) 118 (9) 121 (11) 0.09 
Diastolic blood pressure (mmHg) 74 (8) 73 (8) 74 (8) 0.37 
Use of antihypertensives, n (%) 2 (2%) 0 (0%) 2 (4%) 0.18 
Weight (kilogram) 71 [63-82] 63 [59-68] 82 [77-85] <0.001 
GFR absolute (mL/min) 118 (17) 112 (13) 125 (18) <0.001 
GFR normalized for height
*





59 (8) 56 (6) 63 (9) <0.001 
GFR during dopamine (mL/min) 128 (19) 122 (17) 135 (19) 0.001 
GFR during dopamine per kidney
† 
(mL/min) 
64 (10) 61 (9) 68 (9) 0.001 




35 (5) 33 (4) 37 (5) 0.001 






38 (6) 36 (5) 40 (6) 0.001 
 
Renal functional reserve (mL/min) 










ERPF (mL/min) 405 (74) 393 (70) 417 (78) 0.18 
ERPF normalized for BSA (mL/min/1.73) 389 (76) 402 (79) 377 (71) 0.10 
ERPF normalized for height (mL/min/m) 242 (45) 236 (45) 248 (45) 0.19 
ERPF during dopamine (mL/min) 496 (113) 484 (107) 509 (118) 0.28 
Filtration fraction (proportion) 0.30 (0.05) 0.29 (0.05) 0.30 (0.05) 0.14 
Proteinuria (g/24h) 0.0 [0.0-0.2] 0.0 [0.0-0.2] 0.0 [0.0-0.2] 0.72 
Albuminuria (mg/L) 1.3 [0.0-2.9] 1.0 [0.0-2.1] 1.5 [0.0-2.9] 0.61 
GFR, Glomerular Filtration Rate (
125




* calculated as GFR / height (meters) 404 
†
 calculated as absolute GFR / 2 405 
 406 
 407 
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Table 2: Post-donation donor characteristics  408 
Variable 





Systolic blood pressure (mmHg) 118 (11) 115 (11) 121 (11) 0.01 
Diastolic blood pressure (mmHg) 73 (7) 73 (8) 74 (7) 0.30 
Use of antihypertensives, n (%) 2 (2%) 0 (0%) 2 (4%) 0.18 
Weight (kilogram) 70 [63-81] 63 [58-69] 81 [76-86] <0.001 
GFR absolute (mL/min) 76 (13) 70 (9) 82 (13) <0.001 
GFR normalized for height* (mL/min/m) 45 (7) 42 (5) 48 (8) <0.001 
GFR during dopamine (mL/min) 80 (12) 76 (10) 84 (13) 0.002 




47 (7) 45 (6) 49 (7) 0.005 
Renal functional reserve (mL/min) 4 (6) 6 (5) 1 (7) 0.002 
Renal functional reserve change† 
(mL/min) 
-1 (7) 1 (7) -4 (6) 0.003 
ERPF (mL/min) 286 (49) 270 (45) 300 (49) 0.04 
ERPF normalized for BSA (mL/min/1.73) 271 (47) 271 (48) 270 (47) 0.93 
ERPF normalized for height (mL/min/m) 242 (45) 236 (45) 248 (45) 0.02 
ERPF during dopamine (mL/min) 322 (65) 311 (63) 333 (67) 0.11 
Filtration fraction (proportion) 0.28 (0.04) 0.27 (0.04) 0.29 (0.04) 0.14 
Proteinuria (g/24h) 0.0 [0.0-0.2] 0.0 [0.0-0.1] 0.1 [0.0-0.2] 0.28 
Albuminuria (mg/L) 2.3 [0.8-3.0] 2.3 [1.0-3.0] 2.3 [0.5-3.0] 0.57 
 409 
GFR, Glomerular Filtration Rate (
125





calculated as GFR / height (meters) 412 
†
 calculated as post-donation RFR – pre-donation RFR per kidney  413 
 414 
 415 
   416 
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Table 3: Linear regression analysis of BMI and change in renal functional reserve 417 
Crude (R
2
=0.06) St. β P 





=0.21)   
    Age -0.29 0.008 
    Systolic blood pressure  0.20 0.12 
    Diastolic blood pressure  0.03 0.81 
    GFR   -0.09 0.42 
    BMI -0.33 0.004 
 418 
BMI, Body Mass Index (kg/m
2
); GFR, Glomerular Filtration Rate (125I-Iothalamate) 419 
Model 1: donor BMI at donation 420 
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